ENLV Projected Dividend Yield
Ord/Enlivex Therapeutics Ltd ( NASDAQ : ENLV )Enlivex Therapeutics is a clinical stage immunotherapy company, developing Allocetra™, a cell therapy designed to reprogram macrophages into their homeostatic state. Co. is focused on three main clinical verticals: sepsis; COVID-19; and solid tumors (the Indications). Co. is developing Allocetra™ as an adjunctive immunomodulating cell therapy for avoiding organ failure caused by sepsis. The drug would be administered intravenously to the patient following the diagnosis of sepsis in addition to standard of care treatment. Co. is also developing Allocetra™ as a solid cancer immunotherapy. 20 YEAR PERFORMANCE RESULTS |
ENLV Dividend History Detail ENLV Dividend News ENLV Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |